These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6682326)

  • 21. [The role of the exercise test in the differentiated treatment of patients with hypertension].
    Liusov VA; Bakhshaliev AB; Ibragimov MA
    Klin Med (Mosk); 1988 Oct; 66(10):64-8. PubMed ID: 3236786
    [No Abstract]   [Full Text] [Related]  

  • 22. [Betaxolol versus nifedipine in the treatment of essential hypertension].
    Steiner A; Hany S; Bättig B; Jenni R; Troesch M; Willimann P; Graf A; Leutenegger F; Angehrn V; Beck G
    Schweiz Rundsch Med Prax; 1988 Oct; 77(41):1101-3. PubMed ID: 2907178
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical results with carteolol in patients with arrhythmias].
    Strösser W
    Arzneimittelforschung; 1983; 33(2a):339-45. PubMed ID: 6682327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative long-term vasoactive effects of atenolol and carteolol on the properties of the small and large arteries of the upper extremities in human essential hypertension.
    Merli IP; Levenson J; Filitti V; Simon A
    Clin Pharmacol Ther; 1989 Dec; 46(6):686-92. PubMed ID: 2689046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A long term clinical trial of carteolol in the management of glaucoma. Belgian Carteolol Study Participants.
    Vercruysse K; Goethals M; Vandeputte O; Missotten L
    Bull Soc Belge Ophtalmol; 1992; 245():75-80. PubMed ID: 1344751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of essential hypertension. A comparison between nadolol, once daily, and propranolol, four times daily.
    Frithz G
    Practitioner; 1982 Mar; 226(1365):562-4. PubMed ID: 7045847
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of the renal effects of dilevalol and carteolol in patients with mild to moderate essential hypertension.
    Baba T; Murabayashi S; Tomiyama T; Takebe K
    Eur J Clin Pharmacol; 1990; 38(3):305-7. PubMed ID: 2187701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hypertension treatment in the practice. Study with the beta receptor blocker bupranolol].
    Schrey A
    Med Welt; 1981 Jan; 32(2):58-62. PubMed ID: 6259489
    [No Abstract]   [Full Text] [Related]  

  • 29. Long-term treatment of angina pectoris with carteolol: a new beta-adrenergic receptor blocking agent.
    Luther RR; Glassman HN; Jordan DC; Klepper MJ
    J Int Med Res; 1986; 14(4):167-74. PubMed ID: 3093295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypotensive effect of carteolol on intraocular pressure elevation and secondary glaucoma associated with endogenous uveitis.
    Ohno S; Ichiishi A; Matsuda H
    Ophthalmologica; 1989; 199(1):41-5. PubMed ID: 2761985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of arterial hypertension: comparative study of atenolol + chlorthalidone vs. timolol maleate-hydrochlorthiazide-amiloride association].
    Brandão AP; Oigman W; Albanesi Filho FM
    Arq Bras Cardiol; 1981 Dec; 37(6):495-8. PubMed ID: 7347202
    [No Abstract]   [Full Text] [Related]  

  • 32. [Nadolol, a long-acting beta-blocker, in the treatment of essential arterial hypertension].
    Semplicini A; Pessina AC; Rossi GP; Tagliafierro R; Lusiani L; Castellani V; Bedogni F; Mazzucato A; Ronsisvalle G
    Cardiologia; 1982 Sep; 27(9):853-64. PubMed ID: 6765448
    [No Abstract]   [Full Text] [Related]  

  • 33. [Monotherapy of hypertension with a beta-receptor blocker].
    Grund R; Schrey A
    ZFA (Stuttgart); 1982 Nov; 58(31):1733-7. PubMed ID: 7180143
    [No Abstract]   [Full Text] [Related]  

  • 34. Phase III long-term study and comparative clinical study of nipradilol ophthalmic solution in patients with primary open-angle glaucoma and ocular hypertension. Part 2.
    Kanno M; Araie M; Masuda K; Takase M; Kitazawa Y; Shiose Y; Azuma I; Ogawa N; Ohdo S
    Arzneimittelforschung; 2006; 56(12):820-5. PubMed ID: 17260669
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical evaluation of bevantolol hydrochloride in patients with severe hypertension. The Cooperative Study Group on Bevantolol in Japan.
    Noshiro T; Miura Y; Yoshinaga K; Iimura O; Inagaki Y; Saruta T; Ishii M; Yamazaki N; Arakawa K
    Int J Clin Pharmacol Ther; 1995 Apr; 33(4):240-5. PubMed ID: 7620695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antihypertensive action of various talinolol dosages after four week's treatment in comparison with placebo].
    Weigmann I; Terhaag B; Wierich W; Herrmann WM
    Arzneimittelforschung; 1998 Mar; 48(3):240-4. PubMed ID: 9553680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparison between timolol maleate and alphamethyldopa in longterm treatment of essential hypertension (author's transl)].
    G Ital Cardiol; 1981; 11(12):2110-6. PubMed ID: 7346307
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of hypertension with tenormin 100 (atenolol). A general practice study (author's transl)].
    Hiemstra S; Ziegler E
    MMW Munch Med Wochenschr; 1980 Dec; 122(49):1777-80. PubMed ID: 6779149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A double-blind comparison of spironolactone and hydrochlorothiazide in hypertensive patients treated with metoprolol.
    Lavenius B; Hansson L
    Int J Clin Pharmacol Ther Toxicol; 1982 Jun; 20(6):291-5. PubMed ID: 7049966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antihypertensive effects of timolol and of the combination timolol, amiloride and hydrochlorothiazide].
    Cospite M; Ferrara F; Raimondi F; Lo Presti T; Ballo M; Milio G; Meli F
    Clin Ter; 1981 Sep; 98(6):617-26. PubMed ID: 7026143
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.